Towards functional precision medicine? Evidence standards of organoids as patient-specific models

The implications of functional precision medicine (FPM), a strategy aiming to bridge the gap between genomic information and phenotypic complexity through functional testing of treatments on patient-derived organoid (PDO), an advanced form of cell culture, are examined.